Benjamin F. Edwards & Company Inc. trimmed its position in Metlife Inc (NYSE:MET) by 3.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,993 shares of the financial services provider’s stock after selling 706 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in Metlife were worth $849,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Kavar Capital Partners LLC acquired a new position in Metlife in the 2nd quarter valued at $25,000. Motco grew its holdings in Metlife by 160.6% in the 2nd quarter. Motco now owns 516 shares of the financial services provider’s stock valued at $26,000 after buying an additional 318 shares in the last quarter. Coastal Capital Group Inc. bought a new stake in shares of Metlife during the 2nd quarter valued at $30,000. Venturi Wealth Management LLC bought a new stake in shares of Metlife during the 3rd quarter valued at $37,000. Finally, Meeder Asset Management Inc. lifted its position in shares of Metlife by 2,474.2% during the 2nd quarter. Meeder Asset Management Inc. now owns 798 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 767 shares during the period. 74.87% of the stock is currently owned by hedge funds and other institutional investors.
Shares of MET stock opened at $49.58 on Wednesday. The company has a quick ratio of 0.15, a current ratio of 0.15 and a debt-to-equity ratio of 0.21. Metlife Inc has a twelve month low of $37.76 and a twelve month high of $51.16. The company has a market cap of $45.36 billion, a P/E ratio of 9.20, a P/E/G ratio of 1.11 and a beta of 1.12. The business has a fifty day simple moving average of $46.64 and a 200 day simple moving average of $47.45.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Tuesday, November 5th will be given a dividend of $0.44 per share. The ex-dividend date is Monday, November 4th. This represents a $1.76 annualized dividend and a dividend yield of 3.55%. Metlife’s dividend payout ratio is currently 32.65%.
A number of analysts have recently weighed in on the company. B. Riley reiterated a “neutral” rating on shares of Metlife in a research report on Tuesday, October 15th. ValuEngine upgraded Metlife from a “strong sell” rating to a “sell” rating in a research report on Monday, November 4th. Zacks Investment Research downgraded Metlife from a “hold” rating to a “sell” rating and set a $51.00 target price for the company. in a research report on Wednesday, November 6th. UBS Group upped their target price on Metlife from $46.00 to $47.00 and gave the company a “neutral” rating in a research report on Thursday, October 10th. Finally, Citigroup cut their target price on Metlife from $42.00 to $41.00 and set a “sell” rating for the company in a research report on Friday, September 13th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. Metlife currently has a consensus rating of “Hold” and an average target price of $49.51.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Story: What is total return in investing?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.